États-Unis · Plateformes & données · MarketBeat

What Ingredion (INGR) Said on Its Q3 Earnings Call

Publié par MarketBeat · États-Unis il y a 20 min

Ingredion (NYSE:INGR) lowered its full-year outlook after third-quarter profit fell short of expectations, as higher manufacturing costs at its Argo facility, expensive inputs and…

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

What Ingredion (INGR) Said on Its Q3 Earnings Call

À lire aussi

Telus targets $900M annualized cash savings exiting 2028 while projecting $500M AI infrastructure revenue over 3 years

Hims & Hers Health vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy for 2027?

Empery Digital director Tice Brown sells $1,193 in shares

‘I have no financial safety net’: I’m 66, rely on Social Security and have just $500 in savings. What hope do I have?

Nasdaq drops into correction territory — here’s what typically happens next

Warren Buffett’s Berkshire Rose 5% in the Market’s Worst Week Since April 2025

What Ingredion (INGR) Said on Its Q3 Earnings Call

Partager

À lire aussi

Telus targets $900M annualized cash savings exiting 2028 while projecting $500M AI infrastructure revenue over 3 years

Hims & Hers Health vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy for 2027?

Empery Digital director Tice Brown sells $1,193 in shares

‘I have no financial safety net’: I’m 66, rely on Social Security and have just $500 in savings. What hope do I have?

Nasdaq drops into correction territory — here’s what typically happens next

Warren Buffett’s Berkshire Rose 5% in the Market’s Worst Week Since April 2025